1Pui CH,Mulligham CG,Evans WE,et al.Pediatric acute lymphoblastic leukemia:Where are we going and how do we get there[J].Blood,2012,120(9):1165-1174.
2Noble SL,Sherer E,Hannemann RE,et al.Using adaptive model predictive control to customize maintenance therapy chemotherapeutic dosing for childhood acute lymphoblastic leukemia[J].J Theor Biol,2010,264:990-1002.
3Brandalise SR,Pinheiro VR,Aguiar SS,et al.Benefits of the Intermittent Use of 6-Mercaptopurine and Methotrexate in Maintenance Treatment for Low-Risk Acute Lymphoblastic Leukemia in Children:Randomized Trial From the Brazilian Childhood Cooperative Group-Protocol ALL-99[J].J Clin Oncol,2010,28(5):1911.
4Armstrong L,Sharif JA,Galloway P,et al.Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine[J].Alim Pharmacol Therap,2011,34(5):1106-1114.
5Gearry R,Barclay M,Roberts R,et al.Thiopurine methyltransferase and 6-thioguanine nucleotide measurement:early experience of use in clinical practice[J].Int Med Jo,2005,35(6):580-585.
6Jayachandran D,Rundell AE,Hannemann RE,et al.Optimal chemotherapy for leukemia:a model-based strategy for individualized treatment[J].PLo S One,2014,9(10):109623.
7Rotovnik-Kozjek N,Kompan L,Soeters P,et al.Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer:a randomised double blinded,placebo controlled pilot study[J].Clin Nutr,2011,30(5):567-570.
8Topkan E,Parlak C,Topuk S,et al.Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer[J].BMC Cancer,2012,31(2):12:502.
